10 Aug Pierre Fabre
Posted at 20:48h
in
Pierre Fabre Pharmaceuticals (PFP) is the US pharmaceutical subsidiary of Pierre Fabre Laboratories, a leading European pharmaceutical company. PFP is focused on delivering breakthrough therapies for diseases with high unmet needs. PFP has therapies in development for Epstein-Barr virus positive post-transplant lymphoproliferative disease, NRAS-mutant melanoma, non-small cell lung cancer with mutation or amplification of MET, and X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED).